Bacterial Resistance and Therapeutic Outcome Following Three Months of Topical Acne Therapy with 2% Erythromycin Gel Versus Its Vehicle
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Two-hundred-and-eight acne vulgaris patients were enrolled in a 24-week study to determine the bacterial resistance issues associated with the use of a topical 2% erythromycin gel. It consisted of a 12-week randomized, double-blind, parallel-group treatment phase comparing the active gel versus its vehicle followed by a 12-week single-blind regression phase with gel vehicle only. Bacteriological samples were taken from the face, back and nares for quantification by species and antibiotic resistance characteristics. Acne efficacy was assessed through week 12. The prevalence of erythromycin-resistant coagulase-negative Staphylococci on the face was extremely high (87%) at baseline, increased to 98% by week 12 in the erythromycin-treated group and did not change during regression. The density of these resistant organisms also significantly increased with erythromycin treatment with no change during regression. Similar prevalence and density patterns were also observed on the untreated back and in the nares. Nearly all of the resistant isolates were highly resistant (minimal inhibitory concentrations > 128 microg/ml). Resistance development was confined to the macrolide class of antibiotics. No anti-acne efficacy was observed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834 · cited 2×
“The following all products had been correctly distributed and labeled seven-point asymmetrical scale was used: total clearing (1), according to the randomized and blinded treatment code.”
BackgroundMethodPrevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Resistance to Antimicrobial Drugs—A Worldwide Calamity
Kunin, C. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00011 · Cited by 558
Propionibacterium acnes resistance to antibiotics in acne patients
Leyden, J. J., McGinley, K. J., Cavalieri, S., Webster, G. F., Mills, O. H., & Kligman, A. M. (1983) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(83)70005-8 · Cited by 221
Self-citationMiller, Y., Eady, E. A., LACEY, R. W., Cove, J. H., JOANES, D. N., & Cunliffe, W. J. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.829 · Cited by 98
Cited by
Guidelines of care for the management of acne vulgaris
Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.037 · Cited by 1,597
Self-citationThiboutot, D., Gollnick, H., Bettoli, V., Dréno, B., Kang, S., Leyden, J. J., Shalita, A. R., Lozada, V. T., Berson, D., Finlay, A., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.01.019 · Cited by 843
Self-citationGuidelines of care for acne vulgaris management
Strauss, J. S., Krowchuk, D. P., Leyden, J. J., Lucky, A. W., Shalita, A. R., Siegfried, E. C., Thiboutot, D. M., Van Voorhees, A. S., Beutner, K. A., Sieck, C. K., et al. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.048 · Cited by 552
Self-citationGuidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
European Evidence‐based (S3) Guidelines for the Treatment of Acne
Nast, A., Dréno, B., Bettoli, V., Degitz, K., Erdmann, R., Finlay, A. Y., Ganceviciene, R., Haedersdal, M., Layton, A., López‐Estebaranz, J. L., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04374.x · Cited by 426
Metadata
- Authors
- Jr, O. M., Thornsberry, C., Cardin, C. W., Smiles, K. A., & Leyden, J. J.
- Venue
- Acta Dermato-Venereologica
- Published
- 2002-07-01
- Volume
- 82
- Issue
- 4
- Pages
- 260-265
- ISSN
- 0001-5555 (ISSN-L)
- OpenAlex
- W2076596273
- Semantic Scholar
- 4ea098fee3b6196270d08c43a3bcb037f9668c05
- Cited by
- 115
- References
- 5
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 8 · 2018: 2 · 2017: 6 · 2016: 19 · 2015: 7 · 2014: 6 · 2013: 2 · 2012: 5
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Acta Dermato Venereologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- acne, erythromycin, topical antibiotics, antibiotic resistance, coagulase-negative staphylococci, macrolide resistance, bacterial density, treatment efficacy
- MeSH terms
- Acne Vulgaris, Administration, Topical, Anti-Bacterial Agents, Double-Blind Method, Erythromycin, Female, Gels, Humans, Male, Skin, Staphylococcus, Treatment Outcome, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacterial Resistance and Therapeutic Outcome Following Three Months of Topical Acne Therapy with 2% Erythromycin Gel Versus Its Vehicle. https://app.cochat.ai/papers/10.1080/000155502320323216
- The paper
- Jr, O. M., Thornsberry, C., Cardin, C. W., Smiles, K. A., & Leyden, J. J. (2002). Bacterial Resistance and Therapeutic Outcome Following Three Months of Topical Acne Therapy with 2% Erythromycin Gel Versus Its Vehicle. Acta Dermato-Venereologica. https://doi.org/10.1080/000155502320323216
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.